Dealflow.eu, together with the European Commission, will host an e-pitching event on 10 December 2020, showcasing some of the most promising European startups from the healthcare sector. Eight EU-funded SMEs will have the opportunity to showcase their innovations, attract the attention of investors, and convince them of their merits for their next financing rounds. Among the 8 selected companies, there are 4 EIC-funded projects with healthcare-focused solutions. Discover their profiles in the EIC Community and learn more about this e-pitching.
The e-pitching event on healthcare will take place digitally, on 10 December 2020 from 3h to 5h pm (CET). At the event, selected early-stage companies from the healthcare sector will have 8 minutes to pitch in front of investors, followed by 4 minutes to Q&A. Dealflow.eu pre-selected the EU-funded startups based on their cutting-edge advancements in tele-health and new ways to tackle the most severe illnesses.
Are you an investor?
You can attend the e-pitching event to discover the pre-selected startups and follow their pitches on healthcare. If you want to participate, reach out to team@dealflow.eu or register here.
Below we present the four EIC-funded companies that will participate in the event:
SDS Optic develops and innovates diagnostics solutions, responding to the needs of patients with cancer with faster and less painful diagnostics. The Polish company received a Phase 2 Grant of 3.985.000 € from the European Innovation Council and won the “Women-led innovation” category of this year’s Innovation Radar Prize.
Capital sought: €5M
MOMM Diagnostics conceives a new generation of in-vitro diagnostic tests for early diagnosis of pre-eclampsia. The Swiss project received an EU contribution of € 100 000 with the programme FET Innovation Launchpad to consolidate the intellectual property rights and develop a demonstrator to approach investors.
Capital sought: €0.5M
Alacris Theranostics provides granular insights for the tumour characterisation and then models precise, personalised drug response thanks to the data obtained. The German company received an EU contribution of € 370K with the programme FET (Future and Emerging Technologies).
Capital sought: €3M
Brain+ combines neuroscience with fun games that strive to improve mental capacity and quality of wellbeing. The Danish company creates therapeutic applications for Alzheimer’s treatment and prevention and received an EU contribution of €2.2M with the programme FTI (Fast Track to Innovation).
Capital sought: €2M
DISCLAIMER: This information is provided in the interest of knowledge sharing and should not be interpreted as the official view of the European Commission, or any other organisation.